TRXADE GROUP, INC. Uncategorized Contracts & Agreements
12 Contracts & Agreements
- Supplier Agreement (Filed With SEC on October 13, 2023)
- Form of Lock-Up Agreement (Filed With SEC on July 31, 2023)
- Amendment to Acquisition Letter, dated June 23, 2023 by and between TRxADE Health, Inc. and Superlatus, Inc (Filed With SEC on June 23, 2023)
- Binding Letter of Intent, dated June 22, 2023 by and between TRxADE Health, Inc. and Superlatus, Inc (Filed With SEC on June 23, 2023)
- Description of Registered Securities (Filed With SEC on March 27, 2023)
- Second Amendment to Offer Letter between TRxADE HEALTH, Inc. and Janet Huffman dated January 17, 2023 and effective September 1, 2022 (Filed With SEC on January 20, 2023)
- Amendment to Offer Letter with Ms. Huffman (Filed With SEC on September 1, 2022)
- Form of Mutual Nondisclosure Agreement (Trxade, Inc.) (Filed With SEC on April 1, 2022)
- Offer Letter dated February 3, 2022, between Trxade, Inc. and Janet Huffman (Filed With SEC on April 1, 2022)
- Description of Registered Securities (Filed With SEC on March 28, 2022)
- Masters Drug Company, Inc. and its Affiliated Companies Terms and Conditions dated March 1, 2022, provided by Integra Pharma Solutions, LLC (Filed With SEC on March 4, 2022)
- Description of Registered Securities (Filed With SEC on March 30, 2020)
